Skip to content

Drug interactions

Dihydroergotamine intranasal + Lithium

Severity: Minor

Dihydroergotamine intranasal and Lithium: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents have serotonergic activity, and lithium can enhance serotonergic transmission. Used together they may add to the risk of serotonin toxicity, although the clinical evidence is limited. Intranasal dihydroergotamine is used intermittently, so exposure is short.

What this interaction means in plain words

Dihydroergotamine intranasal and Lithium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Possible additive serotonergic effects, supported mainly by theoretical considerations.

What to do

Counsel the patient to report agitation, tremor, sweating, diarrhea or fever after dosing. Stop the serotonergic agents and assess the patient if serotonin syndrome is suspected.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dihydroergotamine intranasal and Lithium, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dihydroergotamine intranasal with Lithium?

MediHelp rates the interaction as minor. Dihydroergotamine intranasal and Lithium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Both agents have serotonergic activity, and lithium can enhance serotonergic transmission. Used together they may add to the risk of serotonin toxicity, although the clinical evidence is limited. Intranasal dihydroergotamine is used intermittently, so exposure is short.

How serious is the interaction between Dihydroergotamine intranasal and Lithium?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Counsel the patient to report agitation, tremor, sweating, diarrhea or fever after dosing. Stop the serotonergic agents and assess the patient if serotonin syndrome is suspected.

What other medicines interact with Lithium?

MediHelp also lists interactions of Lithium with, for example, Thioridazine, Vandetanib, Aceclofenac. The full list is on the Lithium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in